The Hidden Risks of BPC157: What Patients Need to Know About Contamination and Safety Regenexx at New Regeneration Orthopedics An FDA Reversal on Peptides Could Open the Market to Unsafe Drugs ProPublica FDA May Reverse Ban on 14 PeptidesWhat It Means for Your Beauty Routine Allure The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York BPC 157: Experimental Peptide Creates Risk for Athletes